Marjolein Sluijter

NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines

Nadine van Montfoort, Linda Borst, Michael Korrer et al. · Cell · 2018 · 317 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Immunology +10

Local Activation of CD8 T Cells and Systemic Tumor Eradication without Toxicity via Slow Release and Local Delivery of Agonistic CD40 Antibody

Marieke F. Fransen, Marjolein Sluijter, Hans Morreau et al. · Clinical Cancer Research · 2011 · 153 citations

Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model

Sumit Kumar, Mark J.A. Schoonderwoerd, Jessie S. Kroonen et al. · Gut · 2022 · 120 citations · Full text

Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy

Marit J van Elsas, Jim Middelburg, Camilla Labrie et al. · Cancer Cell · 2024 · 116 citations · Full text

Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2

Margit H. Lampen, Marjolein Sluijter, Annemieke Geluk et al. · Molecular Immunology · 2012 · 106 citations

Histocompatibility, Hla, Signal Transduction +13